Compare GRFS & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | AX |
|---|---|---|
| Founded | 1940 | 1999 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.0B |
| IPO Year | N/A | 2004 |
| Metric | GRFS | AX |
|---|---|---|
| Price | $7.64 | $90.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.15 | ★ $103.14 |
| AVG Volume (30 Days) | ★ 569.0K | 273.8K |
| Earning Date | 07-28-2022 | 04-30-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.33 |
| Revenue | N/A | ★ $65,789,000.00 |
| Revenue This Year | $4.49 | $24.76 |
| Revenue Next Year | $6.42 | $10.86 |
| P/E Ratio | $18.67 | ★ $14.10 |
| Revenue Growth | N/A | ★ 1.78 |
| 52 Week Low | $7.26 | $69.25 |
| 52 Week High | $11.14 | $101.92 |
| Indicator | GRFS | AX |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 58.60 |
| Support Level | $7.64 | $84.96 |
| Resistance Level | $8.24 | $100.31 |
| Average True Range (ATR) | 0.18 | 1.95 |
| MACD | -0.01 | 0.57 |
| Stochastic Oscillator | 44.02 | 83.43 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.